Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-05-31
1996-03-12
Gupta, Yogendra N.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548255, 5482648, 5483265, A61K 3141, C07D24906
Patent
active
054986206
ABSTRACT:
A compound having the formula: ##STR1## and pharmaceutically acceptable salts thereof.
REFERENCES:
patent: 4299834 (1981-11-01), Austel
patent: 4590201 (1986-05-01), Bochis
patent: 4659720 (1987-04-01), Chabala
patent: 4816469 (1989-03-01), Bochis
patent: 4847257 (1989-07-01), Hupe
patent: 5045543 (1991-09-01), Hupe
patent: 5132315 (1992-07-01), Kohn
Lovelette, C. A., et al. "Studies in Nonbridgehead Fused Nitrogen Heterocycles. Fused 1,2,3-Triazoles", J. Org. Chem., vol. 37, No. 25, pp. 4124-4128, 1972.
Hamilton, Thomas C., et al., "Characterization of a Xenograft Model of Human Ovarian Cancer Which Produces Ascites and Intraabdominal Carcinomatosis in Mice", Cancer Research, vol. 44, pp. 5286-5290, 1984.
Allen, Lee F., et al. "G-protein-coupled receptor genes as protooncogenes: Constitutively activating mutation of the .alpha..sub.1B -adrenergic receptor enhances mitogenesis and tumorigenicity", Proc. Natl. Acad. Sci. USA, vol. 88, pp. 11354-11358, 1991.
Julius, David, et al., "Ectopic Expression of the Serotonin 1c Receptor and the Triggering of Malignant Transformation", Science, vol. 244, pp. 1057-1062, 1989.
Jelsema, Carole L., et al., "Stimulation of phospholipase A.sub.2 activity in bovine rod outer segments by the .beta..gamma. subunits of transducin and its inhibition by the a subunit", Proc. Natl. Acad. Sci. USA, vol. 84, pp. 3623-3627, 1987.
Liotta, Lance, A., et al., "Tumor cell autocrine motility factor", Proc. Natl. Acad. Sci. USA, vol. 83, pp. 3302-3306, 1986.
Gutkind, J. Silvio, "Muscarinic acetylcholine receptor subtypes as agonist-dependent oncogenes", Proc. Natl. Acad. Sci. USA, vol. 88, pp. 4703-4707, 1991.
Landis, Claudia, A., et al., "TGPase inhibiting mutations activate the .alpha. chain of G.sub.S and stimulate adenylyl cyclase in human pituitary tumours", Nature, vol. 340, pp. 692-696, 1989.
Fleischman, Laurie, F., et al., "Ras-Transformed Cells: Altered Levels of Phosphatidylinositol-4,5-bisphosphate and Catabolites", Science, vol. 231, pp. 407-410, 1986.
Alonso, Teresa, et al., "Malignant transformation by ras and other oncogenes produces common alterations in inositol phospholipid signaling pathways", Proc. Natl. Acad. Sci. USA, vol. 85, pp. 4271-4275, 1988.
Pozzatti, R., et al., "Primary Rat Embryo Cells Transformed by One or Two Oncogenes Show Different Metastatic Potentials", Science, vol. 232, pp. 223-227, 1986.
Jackowski, Suzanne, et al., "A Guanine Nucleotide-dependent Phosphatidylinositol 4,5-Disphosphate Phospholipase C in Cells Transformed by the v-fms and v-fes Oncogenes", The Journal of Biological Chemistry, vol. 261, No. 11, pp. 4978-4985, 1986.
Church, Jon G., "G-protein-mediated Epiderma Growth Factor Signal Transduction in a Human Breast Cancer Cell Line", The Journal of Biological Chemistry, vol. 263, pp. 4242-4246, 1988.
Ashkenazi, Avi, et al., "Acetylcholine analogue stimulates DNA synthesis in brain-derived cells via specific muscarinic receptor subtypes", Letters to Nature, pp. 146-150, 1989.
Young, Dallan, et al., "Isolation and Characterization of a New Cellular Oncogene Encoding a Protein with Multiple Potential Transmembrane Domains", Cell, vol. 45, pp. 711-719, 1986.
Kohn, Elise, C., et al., "In Vivo Efficacy of a Novel Inhibitor of Selected Signal Transduction Pathways Including Calcium, Arachidonate, and Inositol Phosphates", Cancer Research, vol. 52, pp. 3208-3212, 1992.
Stracke, Mary, L., et al., "Pertussis Toxin Inhibits Stimulated Motility Independently of the Adenylate Cyclase Pathway in Human Melanoma Cells", Biochemical and Biophysical Research Communications, vol. 146, No. 1, pp. 339-345, 1987.
Allende, Jorge, E., "GTP-mediated macromolecular interactions: the common features of different systems", pp. 2356-2367, 1988.
Neer, Eva J., et al., "Roles of G Protein subunits in transmembrane signaling", Nature, vol. 333, pp. 129-134, 1988.
Berridge, Michael, J., et al., "Inositol Trisphosphate and Diacylglycerol: Two Interacting Second Messengers", Ann. Rev. Biochem., vol. 56, pp. 159-193, 1987.
Hupe, Donald J., et al., "The Inhibition of Receptor-mediated and Voltage-dependent Calcium Entry by the Antiproliferative L-651,582", The Journal of Biological Chemistry, vol. 266, No. 16, pp. 10136-10142, 1991.
Kohn, Elise, C., et al., "Autocrine Motility Factor Stimulates a Three-Fold Increase in Inositol Trisphosphate in Human Melanoma Cells", Biochemical and Biophysical Research Communications, vol. 166, No. 2, pp. 757-764, 1990.
Kohn, Elise, C., et al., "Autocrine Motility Factor Stimulates Phosphatidyl-Inositol Turnover in Human Melanoma Cells", Proceedings of AACR, vol. 29, 1988.
Kohn, Elise, C., et al., "L651582: A Novel Antiproliferate and Antimetastasis Agent", Journal of the National Cancer Institute, vol. 82, No. 1, 1990.
Kohn, Elise, C., et al., "L651582, A Novel Antiproliferate and Antimetastasis Agent Which Interferes with Guanine Nucleotide-Binding Protein Function", Journal of National Cancer Institute, vol. 82, No. 1, 1990.
Merritt, Janet E., et al., "SK&F 96365, a novel inhibitor of receptor-mediated calcium entry", Biochem. J., vol. 271, pp. 515-522, 1990.
Felder, Christian C., et al., "The Antiproliferative and Natimetastatic Compound L651582 Inhibits Muscarinic Acetylcholine Receptor-Stimulated Calcium Influx and Arachidonic Acid Release", Journal of Pharmacology and Experimental Therapeutics, vol. 257, No. 23, pp.967-971, 1991.
Jones, David, T., et al., "Biochemical Characterization of Three Stimulatory GTP-binding Proteins", The Journal of Biological Chemistry, vol. 265, No. 5, pp. 2671-2676, 1990.
Felder Christian C.
Kohn Elise C.
Liotta Lance A.
Gupta Yogendra N.
The United States of America as represented by the Department of
LandOfFree
Signal transduction inhibitor 1,2,3-triazolo compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Signal transduction inhibitor 1,2,3-triazolo compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Signal transduction inhibitor 1,2,3-triazolo compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2100139